Baijin Life Science's (HKG:1466) board lot size of shares for trading on the Hong Kong bourse will be reduced to 8,000 shares from 32,000 shares, a Monday Hong Kong bourse filing said.
Shares of the jewelry maker were down over 3% in Tuesday afternoon trading.
The change is expected to become effective Dec. 8.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.